The evidence for resection post-selective internal radiation therapy

被引：2

作者：

Garlipp, Benjamin ^{[1
]}

Bruns, Christiane J. ^{[1
]}

机构：

[1] Otto Von Guericke Univ, Univ Hosp Magdeburg, Dept Surg, D-39120 Magdeburg, Germany

来源：

FUTURE ONCOLOGY | 2014年 / 10卷 / 15期

关键词：

downstaging; hepatocellular carcinoma; liver; metastases; parenchymal hypertrophy; selective internal radiation therapy; UNRESECTABLE HEPATOCELLULAR-CARCINOMA; LIVER METASTASES; Y-90; MICROSPHERES; CHEMOTHERAPY; RADIOEMBOLIZATION; TRIAL; CHEMOEMBOLIZATION; SIR-SPHERES(R); HEPATECTOMY; SURGERY;

D O I：

10.2217/fon.14.223

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：49 / 52

页数：4

共 28 条

[1] Hepatic volume changes induced by radioembolization with 90Y resin microspheres. A single-centre study [J].

Ahmadzadehfar, Hojjat ;

Meyer, Carsten ;

Ezziddin, Samer ;

Sabet, Amir ;

Hoff-Meyer, Anja ;

Muckle, Marianne ;

Logvinski, Timur ;

Schild, Hans Heinz ;

Biersack, Hans Juergen ;

Wilhelm, Kai .

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2013, 40 (01) :80-90

[2] Hepatectomy after hepatic arterial therapy with either yttrium-90 or drug-eluting bead chemotherapy: is it safe? [J].

Brown, Russell E. ;

Bower, Matthew R. ;

Metzger, Tiffany L. ;

Scoggins, Charles R. ;

McMasters, Kelly M. ;

Hahl, Michael J. ;

Tatum, Cliff ;

Martin, Robert C. G. .

HPB, 2011, 13 (02) :91-95

[3]

Chua TC, 2010, ANTICANCER RES, V30, P3005

[4] Multi-centre phase II clinical trial of yttrium-90 resin microspheres alone in unresectable, chemotherapy refractory colorectal liver metastases [J].

Cosimelli, M. ;

Golfieri, R. ;

Cagol, P. P. ;

Carpanese, L. ;

Sciuto, R. ;

Maini, C. L. ;

Mancini, R. ;

Sperduti, I. ;

Pizzi, G. ;

Diodoro, M. G. ;

Perrone, M. ;

Giampalma, E. ;

Angelelli, B. ;

Fiore, F. ;

Lastoria, S. ;

Bacchetti, S. ;

Gasperini, D. ;

Geatti, O. ;

Izzo, F. .

BRITISH JOURNAL OF CANCER, 2010, 103 (03) :324-331

[5] Neoadjuvant treatment of unresectable colorectal liver metastases:: correlation between tumour response and resection rates [J].

Folprecht, G ;

Grothey, A ;

Alberts, S ;

Raab, HR ;

Köhne, CH .

ANNALS OF ONCOLOGY, 2005, 16 (08) :1311-1319

[6] Tumour response and secondary resectability of colorectal liver metastases following neoadjuvant chemotherapy with cetuximab: the CELIM randomised phase 2 trial [J].

Folprecht, Gunnar ;

Gruenberger, Thomas ;

Bechstein, Wolf O. ;

Raab, Hans-Rudolf ;

Lordick, Florian ;

Hartmann, Joerg T. ;

Lang, Hauke ;

Frilling, Andrea ;

Stoehlmacher, Jan ;

Weitz, Juergen ;

Konopke, Ralf ;

Stroszczynski, Christian ;

Liersch, Torsten ;

Ockert, Detlev ;

Herrmann, Thomas ;

Goekkurt, Eray ;

Parisi, Fabio ;

Koehne, Claus-Henning .

LANCET ONCOLOGY, 2010, 11 (01) :38-47

[7] Left-Liver Hypertrophy After Therapeutic Right-Liver Radioembolization Is Substantial but Less Than After Portal Vein Embolization [J].

Garlipp, Benjamin ;

de Baere, Thierry ;

Damm, Robert ;

Irmscher, Romy ;

van Buskirk, Mark ;

Stuebs, Patrick ;

Deschamps, Frederic ;

Meyer, Frank ;

Seidensticker, Ricarda ;

Mohnike, Konrad ;

Pech, Maciej ;

Amthauer, Holger ;

Lippert, Hans ;

Ricke, Jens ;

Seidensticker, Max .

HEPATOLOGY, 2014, 59 (05) :1864-1873

[8] Randomised trial of SIR-Spheres® plus chemotherapy vs. chemotherapy alone for treating patients with liver metastases from primary large bowel cancer [J].

Gray, B ;

Van Hazel, G ;

Hope, M ;

Burton, M ;

Moroz, P ;

Anderson, J ;

Gebski, V .

ANNALS OF ONCOLOGY, 2001, 12 (12) :1711-1720

[9]

Gulec SA, 2013, AM J CLIN ONCOL-CANC, V36, P455

[10]

Inarrairaegui M, 2012, EUR J SURG ONCOL, V38, P594

← 1 2 3 →